Relief Therapeutics

Supporting patients through science and innovation

Relief Therapeutics Holding AG (SIX: RLF) is a Swiss-based publicly-traded drug development company focusing primarily on the clinical development of peptides and proteins of natural or engineered origin to address unmet medical needs. Our expertise covers the entire R&D lifecycle up to market approval.